Lilly seeks to expand pain pipeline with $1B acquisition

Please subscribe to IBJ to decode this article.

l auelys iId Lyea saq ncusnFnumeicdio nSyglenloountvrbiaaCerO di ooiiodi.dposan nl ail $Sben eho cptctc e ewa cearahtonscotnpnl Tar opbEl.1Ta to.-cpyn aetni urhi

ea he1iadith.shinarb srnirsa,as iiiC.tdft2 eetrd t tnneihtpi in0 yt pnntbeh trr0euo 2sneii ul4apui ynoen epo c tia iehdttet dohrlahg rty Ss cn Pisgodt-hsv i.sT81 tO-od0dsaee naCm ent 0l andnerlSambi edasoeromhatyea vexn,oartlaid Ntofpooye ngasyi ,o

nanypretn0ctnong4prdirioiiieip- ehl,sTntiesatloc-hn xta r gee S-idn.roo 0 a mnoe t trf CmeLa

oIfisnheitdtie dnnnonhvonpe rsbcaCiMicterr eidttnr geLctnifaynttaa ra na c sineneeerreatdeeLlei ne uetitDcnloa r-Mnlevtaut hatp.i Tgeyi e o efies hoifn, u,St oos gpNr eatidofoen ie.uw dfpssaera owssttmhiatee aklreen otn ic oOf,it aisrvotcnt m0ntna vciundh tdsm slh"niavpnn emenmci" ee pi o" r h es efim sronetnreo rmorldlt uon einl0an.cTemuansgaar" e ooeee m- nseieaosi ropt ev udicaca e pkauuid4ionpatslto ediditrv ere , glidrnencRnadwspicetuoevnn- f sadmto fnSbltoit, lpholanrol

.ilpesgsnndada syaoupdt mndnty nc edlnele ie ncsn osplcsdos Ldin t anThe.cddsslluepby- dnail eeetauilmraaemt oi o eticexf de o t

nadroa0oaalonln me1Sy eTe o4n hcNdlfLk ioe dnfsgh-o,e eiieyf hmlseldoiehsb$ rrogrhsromiao p icot.i0s0 nsnaldnrvttgvnoro bf N SlenN cdi tsoi lir r r t H hnaeelhOtig ott rni0no ddwt rCyivelea,opeefao

anueiryrihst nntiuWrn pon"neeocs 4drroodth aeburet 0-ncfot .roomoenktd phppehtsfa o, eeizft O,soextlortin r ei ieciaai rm"oo -iooeeviypidcn ppuiccle et ds md ealelhtfwoe OlvifeSeeiipvaiusnweeadt.r rrropa. hgbafre n'dfvcseeattvebt mndulmiseel ntatf oiaorgso,tf ede aioeaieotrm Cvnoeug prll e ertrn CegaeoaM opri r eapmullsioscaetnin ol tsaorsef,yf eeoevoamnitsn td,geefi,t lnShitm-nnd dioeas0e"nraerefdlll r bhwes tat nc ire hild ib,eec,niat rLrapaOudtnote"n i Tvf tcc cSh arrnoie cAdedreir neaJi nr incf Eassaldiadiy yslen

r anh.,Lpilr uur7maed7 re s tslSny3 aae ral eisTeet%y1ew. d2a po0ydhiy$

bn& s;p